divislab glp-1 novo nordisk boom lifts Nordisk, buries WeightWatchers Undeterred by Novo Nordisk failure,

HENDERSON, NV, March 12, 2025 (GLOBE NEWSWIRE) -- PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support Patch Collectiona targeted solution designed to complement individuals using GLP-1 receptor agonist medications such as Ozempic, Wegovy, and Mounjaro for weight management

This innovative, FDA-approved treatment supports safe, effective weight management, helping you maintain long-term results.

Sana Umar, FRCP.

Protocol 2 included 81617 initiators of GLP-1 receptor agonists (n=16768) and SGLT-2 inhibitors (n=64849)

See how this mix affects your heart, blood pressure, and alertness & when it becomes an emergency.